RxDoctor Payments DataLook up a doctor →

Hisham Abdel Azim

Pediatric Hematology-Oncology · Los Angeles, CANPI 1114018694

Payments from drug & device makers

$1,299,262in general payments, 2019–2025

Across 997 payments — averaging $1303.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Adaptive Biotechnologies Corporation$1.2M
  • Merck$32K
  • Mallinckrodt Enterprises LLC$14K
  • Vertex$14K
  • Gilead$13K
  • Novartis$8K
  • plus $29K from 12 others

What the payments were for

  • Consulting fees$43,58184%
  • Travel & lodging$4,4259%
  • Food & beverage$4,0308%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,299,262 in reported general payments places this provider in the 90th percentile of 307 pediatric hematology-oncology providers in California.

See all pediatric hematology-oncology providers in California

Other pediatric hematology-oncology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →